Cytokinetics's total assets for Q4 2025 were $1.42B, a decrease of -0.84% from the previous quarter. CYTK total liabilities were $2.08B for the fiscal quarter, a 6.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.